Business
Data-driven Volatility is Hardly a New Phenomenon in Biotech Trading. However, a Bevy of ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'Data-driven volatility is hardly a new phenomenon in biotech trading. However, a bevy of clinical trial read-outs in recent weeks has prompted some eye-popping moves ...'
Data-driven volatility is hardly a new phenomenon in biotech trading. However, a bevy of clinical trial read-outs in recent weeks has prompted some eye-popping moves https://t.co/XwfPysGrqw— Bloomberg (@business) October 24, 2022
(The above story first appeared on LatestLY on Oct 25, 2022 12:59 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
